From mitochondrial dysfunction to amyloid beta formation: novel insights into the pathogenesis of Alzheimer's disease

Topic: Amyloid, tau and blood-test diagnosis

The non-Mendelian sporadic Alzheimer's disease (AD) is the most frequent form of dementia diagnosed worldwide. The most important risk factor to develop sporadic AD is aging itself. Next to hyperphosphorylated Tau, intracellular amyloid beta (Aß) oligomers are known to initiate a cascade of pathological events ranging from mitochondrial dysfunction, synaptic dysfunction, oxidative stress, and loss of calcium regulation, to inflammation. All these events are considered to play an important role in the progressive loss of neurons. The molecular mechanisms determining the balance between Aß production and clearance during the progression of the disease are not well understood. Furthermore, there is cumulating evidence that Aß formation impairs mitochondrial function and that mitochondrial dysfunction is an early event in the pathogenesis of AD. On the other hand, mitochondrial dysfunction, in particular increased formation of mitochondrially derived reactive oxygen species, promote Aß formation. Here, we review these latest findings linking mitochondrial dysfunction and Aß formation. We propose that mitochondrial dysfunction, which is well-known to increase with age, is an initial trigger for Aß production. As Aß itself further accelerates mitochondrial dysfunction and oxidative stress, its formation is self-stimulated. Taken together, a vicious cycle is initiated that originates from mitochondrial dysfunction, implying that AD can be viewed as an age-associated mitochondrial disorder. The proposed mechanism sheds new light on the pathophysiological changes taking place during the progression of AD as well as in the aging process.

Key findings

• Taken together, a vicious cycle is initiated that originates from mitochondrial dysfunction, implying that AD can be viewed as an age-associated mitochondrial disorder.

Study details

• Evidence strengthLow

Read the original

• DOI: 10.1007/s12035-012-8307-4
• PubMed: 22833458
• Original source →

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

@article{leuner2012-22833458,
  author  = {Leuner, K. and Müller, W. E. and Reichert, A. S.},
  title   = {{From mitochondrial dysfunction to amyloid beta formation: novel insights into the pathogenesis of Alzheimer's disease}},
  journal = {Molecular neurobiology},
  year    = {2012},
  doi     = {10.1007/s12035-012-8307-4},
  pmid    = {22833458},
  url     = {https://doi.org/10.1007/s12035-012-8307-4}
}

Related studies in Disease mechanisms

• Synaptic dysfunction in Alzheimer's disease: the effects of amyloid beta on synaptic vesicle dynamics as a novel target for therapeutic intervention Neural regeneration research · 2018-04-01 · usefulness score 41/100
• Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells The Journal of Cell Biology · 2003-04-14 · usefulness score 40/100
• Small-Molecule Inhibitors of Amyloid Beta: Insights from Molecular Dynamics—Part A: Endogenous Compounds and Repurposed Drugs Pharmaceuticals · 2025-02-23 · usefulness score 37/100
• Small-Molecule Inhibitors of Amyloid Beta: Insights from Molecular Dynamics—Part B: Natural Compounds Pharmaceuticals · 2025-09-28 · usefulness score 33/100
• A novel presenilin 1 mutation associated with Pick's disease but not beta-amyloid plaques Annals of neurology · 2004-05-01 · usefulness score 45/100
• S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury Science (New York, N.Y.) · 2009-04-01 · usefulness score 41/100

Similar studies

• The role of abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease 2009 · Disease mechanisms
• Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer's disease 2020 · Risk factors
• The keystone of Alzheimer pathogenesis might be sought in Aβ physiology 2015 · Disease mechanisms
• The molecular pathology of Alzheimer's disease 1991 · Disease mechanisms
• Beta-amyloid, neuronal death and Alzheimer's disease 2001 · Disease mechanisms
• Consequences of Metabolic Disruption in Alzheimer's Disease Pathology 2019 · Disease mechanisms

More on Disease mechanisms

• A review that covers this ground Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks Nature neuroscience · 2010-07-01 · usefulness score 40/100
• Newest in this subject Aβ42 oligomers disrupt calcium homeostasis via Piezo1 and induce neurotoxicity in differentiated SH-SY5Y cells Research Square · 2026-10-29 · Preprint — not yet peer-reviewed · usefulness score 16/100
• Newest in this subject Neuronal Hyperactivity Induces Tau Phosphorylation Selectively in Excitatory Pyramidal Neurons Which Contributes to GluA2 Regulation bioRxiv · 2026-10-28 · Preprint — not yet peer-reviewed · usefulness score 16/100

See all studies in Disease mechanisms →